Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05980234 · ClinicalTrials.gov registry record
MDR - Longevity IT Oblique and Offset Liners
A clinical trial, sponsored by Zimmer Biomet.
- Terminated
- Registry status
- 6
- Enrollment target
NCT05980234: Clinical Trial study, sponsored by Zimmer Biomet.
NCT05980234 is a clinical trial that was terminated before completion, run by Zimmer Biomet. The registered enrollment target is 6 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05980234 was terminated before completion, sponsored by Zimmer Biomet.
- TERMINATED
- Registry status
- 6 participants
- Enrollment target
Study Summary
The objective of this retrospective enrollment/prospective follow-up consecutive series PMCF study is to collect data confirming safety, performance, and clinical benefits of the Longevity IT Oblique and Offset liners when used for primary or revision total hip arthroplasty (implants and instrumentation) at a minimum of 10-year follow-up.
Primary Outcome
This will be assessed by recording the incidence and frequency of revisions, complications, and adverse events with particular focus on those that may be related to the study device.
Interventions
- DEVICE Total Hip Arthroplasty with Longevity IT Oblique Liners
- DEVICE Total Hip Arthroplasty with Longevity IT Offset Liners
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2023-08-30 |
| Est. Completion | 2024-11-07 |
Why NCT05980234 stopped before completion
NCT05980234 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 6 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Total Hip Arthroplasty with Longevity IT Oblique Liners is the first listed.
NCT05980234 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05980234 about?
NCT05980234 is a clinical study titled "MDR - Longevity IT Oblique and Offset Liners". The objective of this retrospective enrollment/prospective follow-up consecutive series PMCF study is to collect data confirming safety, performance, and clinical benefits of the Longevity IT Oblique and Offset liners when used for primary or revision total hip arthroplasty (implants and instrumenta...
What is the current status of trial NCT05980234?
This trial is currently terminated. The enrollment target is 6 participants. The study started on 2023-08-30. Estimated completion is 2024-11-07.
What interventions are being tested in trial NCT05980234?
The interventions under investigation include: Total Hip Arthroplasty with Longevity IT Oblique Liners (DEVICE), Total Hip Arthroplasty with Longevity IT Offset Liners (DEVICE).
Who is sponsoring clinical trial NCT05980234?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI